Kelun-Biotech Announce Exclusive License Agreement For SKB378/HBM9378, an Anti-thymic Stromal Lymphopoietin (TSLP) Monoclonal Antibody (mAb).

Kelun Biotech Announce Exclusive License Agreement For SKB378HBM9378 an Anti thymic Stromal

CHENGDU, China, Jan. 11, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the…

www.investing.com

More posts

Fed doesn't change rates, will slow pace of balance sheet reduction

March 20, 2025
Optinose CEO Mahmoud Ramy A sells $2,064 in common stock

March 20, 2025
Congress on track for stablecoin, market structure bills by August: Blockchain Association

March 20, 2025
Pavel Durov says Telegram now has 1B+ MAUs, up from 950M in July 2024, and made $547M in profits in 2024, and calls WhatsApp "a cheap, watered-down imitation" (Ivan Mehta/TechCrunch)

March 20, 2025